Skip to content

Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram

Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram: a Prospective, Observational Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05888246
Enrollment
412
Registered
2023-06-05
Start date
2022-05-07
Completion date
2022-05-14
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy People

Brief summary

A prospective and observational clinical study of measuring the range of cardiac magnetic parameters in healthy people with the magnetocardiogram manufactured by Hangzhou Nuochi Life Science Co., LTD

Detailed description

This study is a prospective and observational study on the collection of cardiac magnetic signals from healthy subjects by magnetocardiogram. It is expected that 412 subjects will be examined by magnetocardiography, and the range of parameters related to magnetocardiography in healthy subjects will be reported.

Interventions

DIAGNOSTIC_TESTMagnetocardiogram

Magnetocardiogram consists of acquisition and control system (including software) and detection part. Acquisition and control system mainly includes: cabinet, display, host, sensor. The detection part mainly includes: inspection bed, array sensor support frame, magnetic shielding equipment.

Sponsors

Hangzhou Nuochi Life Science Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy people aged 18-70 years old; 2. Subjects receiving physical examination in physical examination institutions, or in other departments other than heart disease (such as orthopedics, gynecology, etc.), or in cardiology department, excluded from coronary heart disease; 3. No history of coronary heart disease; 4. ECG did not indicate myocardial ischemia or infarction; 5. Sinus rhythm without arrhythmia; 6. The subject or the subject's legal representative has been informed of the nature of the study, understands the purpose of the clinical study, voluntarily participates in the study and signs the informed consent.

Exclusion criteria

1. Acute coronary syndrome requires emergency PCI treatment, and it is estimated that magnetic cardiogram examination will affect the timing of emergency PCI surgery; 2. Subjects with metal implants in the thoracic cavity (including the heart cavity), such as those who have received pacemaker therapy or cardiac resynchronization therapy (CRT, CRT-D) or implantable cardioverter defibrillator (ICD) implantation, or those who have received metal heart valve implantation; 3. There is hemodynamic instability, which is defined as systolic blood pressure < 80mmHg, or cardiogenic shock; Or need vasoactive drug therapy; Intra-aortic balloon counterpulsation may be required; Or other hemodynamic support devices; As syndrome; 4. Severe tachycardia (ventricular rate \> 150 beats/min), ventricular flutter, ventricular fibrillation and other malignant arrhythmias; 5. Subjects unable to lie flat (supine position); 6. Subjects with mental illness, unconscious or uncontrollable ability; Or claustrophobic subjects; 7. Other circumstances in which the investigator considers the subject inappropriate for participation in the study

Design outcomes

Primary

MeasureTime frameDescription
PR interval24 hoursPR interval is defined as the position from the starting point of P wave to the starting point of QRS wave after the superposition of 36 channels in the magnetocardiogram (butterfly diagram).
QRS interval24 hoursQRS interval is defined as the time (ms) from the beginning of QRS to the end of QRS after the stacking of 36 channels in the magnetocardiogram (butterfly diagram).
QT interval24 hoursQT interval is defined as the time (ms) from the beginning of Q wave to the end of T wave after the stacking of 36 channels in the magnetocardiogram (butterfly diagram).
Corrected QT interval24 hoursThe corrected QT interval was defined as the QTC interval (ms) after the stacking of 36 channels in the magnetocardiogram (butterfly diagram). QTc = QT/(RR\^0.5), RR is the average RR interval calculated by cardiac magnetic waveform, QT is QT interval.
The magnetic field intensity parameter (R/T ratio)24 hoursThe magnetic field intensity parameter (R/T ratio) is defined as the ratio of the maximum magnetic field intensity of the r-wave vertex to the T-wave vertex of the magnetocardiogram calculated based on the isomagnetic map.
Maximum current vector angle (MCV angle)24 hoursThe Angle of the maximum current vector was measured at the vertex of QRS and T wave respectively.
Maximum current vector amplitude (MCV amplitude)24 hoursThe amplitude of the maximum current vector was measured at the vertex of QRS wave and T wave respectively.
Total current vector angle (TCV angle)24 hoursTCV represents the total current vector, which is the sum of all current vectors of 36 channels in the magnetocardiogram. First calculate the vector sum of the 36 channels, and finally calculate the angles.
Total current vector amplitude (TCV amplitude)24 hoursTCV represents the total current vector, which is the sum of all current vectors of 36 channels in the magnetocardiogram. First calculate the vector sum of the 36 channels, and finally calculate the amplitude.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026